[1]
Kuna, A.K., Seru, G. and Radha, G.V. 2018. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF IMATINIB MESYLATE AND ITS DIMER IMPURITY IN PHARMACEUTICAL FORMULATION BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. Asian Journal of Pharmaceutical and Clinical Research. 11, 3 (Mar. 2018), 136–139. DOI:https://doi.org/10.22159/ajpcr.2018.v11i3.21073.